Author:
Nagahori Masakazu, ,Kochi Shuji,Hanai Hiroyuki,Yamamoto Takayuki,Nakamura Shiro,Omuro Soji,Watanabe Mamoru,Hibi Toshifumi
Funder
Kyorin Pharmaceutical Co., Ltd.
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,General Medicine
Reference19 articles.
1. Japan Intractable Diseases Information Center home page. http://www.nanbyou.or.jp/entry/62 Assessed 15 April 2013.
2. Ministry of Health, Labour and Welfare: Shared Study Report FY 2014 on “Research on intractable inflammatory bowel disease” (Suzuki Group), p. 383
3. Wang Y, Parker CE, Feagan BG, MacDonald JK. Oral 5-Aminosalicylic acid for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev. 2016;9:CD000544.
4. Kruis W, Jonaitis L, Pokrotnieks J, Mikhailova TL, Horynski M, Bátovský M, et al. Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis. Aliment Pharmacol Ther. 2011;33:313–22.
5. Dignass AU, Bokemeyer B, Adamek H, Mross M, Vinter-Jensen L, Börner N, et al. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis. Clin Gastroenterol Hepatol. 2009;7:762–9.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献